|
Pharmacokinetics of Isavuconazole in Liver Impairment due to Hepatitis (click for details) |
|
|
|
Bloodstream and Pulmonary Infections in Liver Transplant Patients (click for details) |
|
|
|
Reduced Incidence of Pneumonia and Invasive Pulmonary Aspergillosis After Introduction of Posaconazole Prophylaxis: Data from the Cologne AML Cohort (click for details) |
|
|
|
Epidemiology and Outcome of Hematogenous Candida Meningoencephalitis (HCME) (click for details) |
|
|
|
Cell Wall Synthesis Alteration and Ultra Structural Modification During Paradoxical Growth Effect of Caspofungin of 4 Different Candida Species. (click for details) |
|
|
|
Prophylactic Efficacy of Posaconazole (PSC) against Fusarium solani (FS) with Reduced In Vitro Susceptibility (click for details) |
|
|
|
Comparison of Time-Kill Curves and Post-Antifungal Effects (PAFE) of Anidulafungin, Caspofungin and Micafungin against Fluconazole-Resistant Candida glabrata and Candida parapsilosis (click for details) |
|
|
|
Novel Antifungal Combinations (click for details) |
|
|
|
Miconazole Mucoadhesive Buccal Tablet for the Treatment of OPC in Head and Neck Cancer Patients (click for details) |
|
|
|
Susceptibility Assessment of Aspergillus terreus Over an 18-Year Period in a General Hospital (click for details) |
|
|
